
Please try another search
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. The company’s clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. It has initiated a Phase 2 trial for lorundrostat in hypertensive patients with stage 2 to 3b chronic kidney disease and a pivotal clinical program of lorundrostat for the treatment of uncontrolled or resistant hypertension. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Name | Age | Since | Title |
---|---|---|---|
Daphne Karydas | 51 | 2023 | Independent Director |
Glenn P. Sblendorio | 69 | 2023 | Independent Chairman |
Annet Kirabo | - | - | Member of Scientific Advisory Board |
Jennifer B. Green | - | - | Member of Scientific Advisory Board |
Reena Mehra | - | - | Member of Scientific Advisory Board |
Krishna R. Polu | 52 | - | Member of Scientific Advisory Board |
Brian Taylor Slingsby | 48 | 2019 | Founder & Executive Director |
Matthew R. Weir | - | - | Member of Scientific Advisory Board |
Derek Paul DiRocco | 44 | 2022 | Independent Director |
Jon Congleton | 62 | 2020 | President, CEO & Director |
Srinivas Akkaraju | 57 | 2021 | Independent Director |
James Matthew Luther | - | - | Member of Scientific Advisory Board |
Alexander M. Gold | 59 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review